Search Results for “”

1

Havas Health & You Appoints Dan Rubin as President of Havas Health +

May 19, 2022 /in Appointments, Healthcare Communications Agencies, Healthcare Communications Networks, New Hire, People on the Move

To continue to support health and wellness companies’ rapidly expanding cultural relevance and dominance of global content, Havas Health & You (HH&Y) announced that industry veteran Dan Rubin will join the network. He will work closely with global executive leadership and existing President and CCO Allison Ceraso to shape the future vision for Havas Health +, a fully integrated experience agency on the rise. Havas Health + has generated double-digit growth for the past 3 years, growing both HCP and DTC practices through new client wins and brand launches.

2

Massachusetts identifies first 2022 U.S. case of monkeypox infection

May 19, 2022 /in Britain, Canada, CDC, Europe, Massachusetts, Monkeypox, Portugal, Zoonotic Diseases

The Massachusetts Department of Public Health on May 17 said it had confirmed a single case of monkeypox virus infection in a man who had recently traveled to Canada.

3

EMA Accepts Filing of Marketing Authorization Application for Valneva’s Inactivated COVID-19 Vaccine Candidate

May 19, 2022 /in Committee for Medicinal Products for Human Use (CHMP), COVID-19 Vaccinations, Europe, European Commission, European Medicines Agency, Marketing Authorization Application (MAA), R&D, Vaccine Companies, Valneva

Valneva SE confirmed that the European Medicines Agency accepted the filing of a marketing authorization application (MAA) for the specialty vaccine company’s inactivated, whole-virus COVID-19 vaccine candidate, VLA2001.

4

Report: Pfizer, NIH Discussing Study of Longer Paxlovid Dosing Regimen

May 18, 2022 /in Antivirals, Clinical Trials, COVID-19 cases, COVID-19 Studies, COVID-19 Therapeutics, Dr. Anthony Fauci (Director), Emergency Use Authorization (EUA), National Institutes of Health, Omicron (B.1.1.529) (South Africa), Paxlovid, Pfizer, R&D, Therapeutics

With increasing concerns about COVID-19 reinfection, Pfizer and the National Institutes of Health are discussing potential studies regarding a longer treatment period with the antiviral medication Paxlovid.

5

Greater Than One Appoints New Chief Client Officer

May 18, 2022 /in Appointments, Customers, Healthcare Communications Agencies, Marketing & Advertising, New Hire, People on the Move

Greater Than One, a full-experience marketing agency focused on healthcare, announced that Bindhu Gopalan was appointed Chief Client Officer. She is responsible for overseeing all client engagements at Greater Than One, with a focus on building better healthcare experiences through the agency’s Capability Convergence model.

6

As COVID cases rise, U.S. health officials mull widening additional booster eligibility

May 18, 2022 /in CDC, CDC Director Rochelle Walensky, Coronavirus Disease (COVID-19) Pandemic, COVID-19 booster shots, Hospitalized COVID-19 Patients, United States, White House

Health officials are considering extending the eligibility for a second COVID-19 vaccine booster dose to people under 50 amid a steady rise in cases, with the United States seeing a threefold increase over the past month.

7

Why Pfizer May Be Holding Paxlovid Close to the Chest

May 18, 2022 /in Antivirals, Bloomberg, Clinical Trials, COVID-19 Therapeutics, Drugs for Neglected Diseases Initiative (DNDi), FDA, Hospitalized COVID-19 Patients, Merck, Molnupiravir, Paxlovid, Pfizer, R&D, Symptoms: Coronavirus Disease 2019 (COVID-19), Therapeutics

Reportedly, Pfizer is holding the company’s COVID-19 antiviral therapy Paxlovid under tight control. This is a disappointment to numerous investigators who want to test the antiviral combination therapy with other drugs in case the virus develops resistance to the combo.

8

COVID is rising in the Americas, virus ‘not going away anytime soon’ – PAHO

May 18, 2022 /in Brazil, Central America, COVID-19 cases, COVID-19 Deaths, COVID-19 Infections, COVID-19 protocols, COVID-19 vaccination rates, Mask-wearing, North America, Pan-American Health Organization (PAHO), Social Distancing, World Health Organization

COVID-19 is on the rise again in the Americas as many countries have abandoned measures like masking and social distancing and many lag in vaccination rates, the Pan American Health Organization (PAHO) said on May 18.

9

Greece goes after Novartis for alleged bribery and kickbacks

May 18, 2022 /in Allegations, Bribery, Bribery, Bribery Schemes, Bribery schemes, Bribes, Business, Greece, Kickback Schemes, Kickbacks, Legal, Novartis, Overcharge Probe, Price fixing schemes, Probes, Sandoz, Schemes, Therapeutics

Greece’s Health Minister Thanos Plevris announced plans to sue Novartis over what he alleges are illegal practices. The scandal has been playing out for several years, with Novartis alleged to have paid Greek public officials and health care providers to increase prescriptions for the company’s drugs and maintain higher prices.

10

Researchers may have unlocked mechanism driving inflammation in rheumatoid arthritis

May 18, 2022 /in Active Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS), Atherosclerosis, Atopic Dermatitis (Eczema), Autoinflammatory Diseases, Axial Spondyloarthritis, Crohn's Disease, Immune-Inflammatory Diseases, Immune-Inflammatory Disorders, Inflammatory Diseases, Plaque Psoriasis, Psoriasis, Psoriasis, Psoriatic Arthritis, R&D, Rheumatoid Arthritis, Rheumatoid Arthritis, Scientists, Therapeutics

Researchers at Hokkaido University in Japan, in a collaboration with American scientists, may have identified neural crosstalk as the mechanism that drives widespread inflammation in inflammatory diseases, such as rheumatoid arthritis (RA), psoriasis and atherosclerosis.

New Search

50 search results for: